Riskpilot← Back to searchSign inGet full accessDr Gulins AB
ABActiveOrg 5593684656Återvändsgatan 10Hospital activities · NACE 8610Est. 20221 employees
Revenue 2025
SEK 851K
+54% vs 2024
EBITDA margin
42.7%
+56% vs 2024
Equity ratio
60.7%
Financial strength
Net profit 2025
SEK 284K
+57% vs 2024
| Revenue | SEK 851K | +54% |
| EBITDA | SEK 363K | +56% |
| Net profit | SEK 284K | +57% |
| Total assets | SEK 511K | +27% |
| Equity | SEK 311K | +50% |
| Employees | 1 | — |
Legal name
Dr Gulins AB
Org number
5593684656
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
3 mars 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företagets verksamhet inkluderar uthyrning av legitimerade läkare, konsultverksamhet inom sjukvården, undervisning, forskning inom sjukvård, handel med värdepapper, fast egendom och därmed förenlig verksamhet.
Address
Återvändsgatan 10
Email
gulinsdr@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 270 | 611 | 553 | 851 |
| Staff expenses | −15 | −64 | −53 | −35 |
| EBITDA | 156 | 243 | 232 | 363 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 156 | 243 | 232 | 363 |
| Net financials | — | 0 | 0 | −1 |
| Profit before tax | 156 | 244 | 232 | 362 |
| Tax | −34 | −56 | −51 | −78 |
| Net profit | 122 | 187 | 181 | 284 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 246 | 439 | 404 | 511 |
| Equity | 147 | 212 | 206 | 311 |
| Long-term debt | — | — | — | — |
| Short-term debt | 99 | 227 | 197 | 201 |
| Total debt | 99 | 227 | 197 | 201 |
EBITDA margin
42.7%
This company
15.8%
Market median
+170% vs market
20222025
Equity ratio
60.7%
This company
38.2%
Market median
+59% vs market
20222025
Return on equity
91.5%
This company
18.4%
Market median
+397% vs market
20222025
Net profit margin
33.4%
This company
8.1%
Market median
+312% vs market
20222025
Asset turnover
1.66×
This company
1.12×
Market median
+48% vs market
20222025
Debt / equity
0.65×
This company
0.62×
Market median
+5% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-03-03 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SJ Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
DG Chief Executive Officer | Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Gulins AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sandra Jerkovic Gulin | Deputy Chief Executive Officer | 0 companies |
| Dario Gulin | Chief Executive Officer | 0 companies |